SCHEMBL4747175

SCHEMBL4747175

CC(=O)NCCc1ccc(Nc2ncc3cc(-c4ccncc4)ccc3n2)cc1

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 20/20 0.72
▸ RAF1 P04049 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5129995 0.82 BRAF (0.77) BRAFRAF1
SCHEMBL3034030 0.82 BRAF (0.68) BRAFRAF1
SCHEMBL5132890 0.81 BRAF (0.61) BRAFRAF1
SCHEMBL5133168 0.81 BRAF (0.84) BRAFRAF1
SCHEMBL3031572 0.79 BRAF (1.00) BRAF
SCHEMBL3031569 0.79 BRAF (1.00) BRAF
SCHEMBL3032995 0.79 BRAF (1.00) BRAF
SCHEMBL3029301 0.79 BRAF (0.73) BRAFRAF1
SCHEMBL1803495 0.78 BRAF (0.44) BRAFRAF1
SCHEMBL3034254 0.78 BRAF (1.00) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008120004-A1 COMBINATION OF A MEK- INHIBITOR AND A B-RAF INHIBITOR FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-10-09 — — WO claimed
WO-2008120004-A1 COMBINATION OF A MEK- INHIBITOR AND A B-RAF INHIBITOR FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-10-09 — — WO disclosed
Send feedback